Higher Vitamin D Levels Are Associated with Better Attentional Functions: Data from the NorCog Register.
Vitamin D
dementia
executive function
neurocognitive function
Journal
The journal of nutrition, health & aging
ISSN: 1760-4788
Titre abrégé: J Nutr Health Aging
Pays: France
ID NLM: 100893366
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
28
9
2019
pubmed:
29
9
2019
medline:
29
5
2020
Statut:
ppublish
Résumé
The aim of this cross-sectional study was to evaluate which cognitive domains are mostly affected in persons with vitamin D insufficiency or deficiency, defined as 25(OH)D < 50 nmol/l and < 25 nmol/l, respectively. Data were collected from the Norwegian register for persons assessed for cognitive symptoms (NorCog). 580 persons aged ≥ 65 years were included. The following cognitive and neuropsychiatric tests were used: Mini Mental State Examination, Norwegian Revised Version (MMSE-NR), the Clock Drawing test, the Trail Making Test A and B, the 10-word memory test and the figure copying test from CERAD - immediate and delayed recall, The Controlled Oral Word Association Test -FAS and Boston Naming test. Neuropsychiatric symptoms were assessed by Neuropsychiatric Inventory-Questionnaire and Cornell Scale for Depression in Dementia. Vitamin D-insufficiency was found in approx. 30 % of the study cohort. After adjustment for relevant covariates, higher serum 25(OH)D levels were associated with higher score on MMSE-NR (p=0.032) and 10-word Memory Test, immediate recall (p=0.038), as well as faster execution of Trail Making Test A and B (p=0.038 and p=0.021, respectively). Other tests were not significantly associated with 25(OH)D levels. Higher vitamin D levels appear to be associated with better cognition, especially in areas of executive function and mental flexibility.
Identifiants
pubmed: 31560030
doi: 10.1007/s12603-019-1220-z
doi:
Substances chimiques
Vitamin D
1406-16-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
725-731Déclaration de conflit d'intérêts
As potential conflicts of interest is to be mentioned that Anne-Brita Knapskog is the principal investigator in two drug trials (Roche BN29553 and Boehringer-Ingelheim 1346.0023) which are performed at the memory clinic, Department of Geriatric Medicine at Oslo University Hospital. The other authors declare no financial or other conflict of interest.
Références
Metabolism. 1999 Aug;48(8):1028-32
pubmed: 10459569
Neurology. 2012 Sep 25;79(13):1397-405
pubmed: 23008220
Maturitas. 2018 Jan;107:56-62
pubmed: 29169581
Anal Chem. 2010 Mar 1;82(5):1942-8
pubmed: 20136128
J Gerontol. 1992 May;47(3):P154-8
pubmed: 1573197
Neurology. 1989 Sep;39(9):1159-65
pubmed: 2771064
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:138-45
pubmed: 24239505
PLoS One. 2013 Oct 18;8(10):e76362
pubmed: 24204618
J Clin Endocrinol Metab. 2011 Jan;96(1):53-8
pubmed: 21118827
Exp Gerontol. 2015 Mar;63:41-7
pubmed: 25645292
J Chem Neuroanat. 2005 Jan;29(1):21-30
pubmed: 15589699
BMJ. 2014 Apr 01;348:g2035
pubmed: 24690624
J Intern Med. 2015 Jan;277(1):45-57
pubmed: 24995480
Lancet. 1995 Jul 22;346(8969):207-10
pubmed: 7616799
Appl Neuropsychol. 2007;14(3):208-14
pubmed: 17848131
Eur J Clin Nutr. 2004 Jan;58(1):128-36
pubmed: 14679378
Biochem Soc Trans. 2005 Aug;33(Pt 4):573-7
pubmed: 16042547
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1654-1668
pubmed: 29409006
Osteoporos Int. 2015 Mar;26(3):1137-46
pubmed: 25278297
J Alzheimers Dis. 2012;29(1):51-62
pubmed: 22207005
Neurologia. 2016 Apr;31(3):183-94
pubmed: 26383062
Eur J Neurol. 2015 Jan;22(1):106-15, e6-7
pubmed: 25117780
J Alzheimers Dis. 2016 May 11;53(2):419-44
pubmed: 27176073
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):E4359-66
pubmed: 25267625
Physiol Rev. 1998 Oct;78(4):1193-231
pubmed: 9790574
J Clin Exp Neuropsychol. 2016;38(4):467-77
pubmed: 26708262
Mol Neurodegener. 2016 Mar 01;11:22
pubmed: 26932723
Tohoku J Exp Med. 2012;228(3):189-96
pubmed: 23076256
J Neuroinflammation. 2012 Oct 25;9:244
pubmed: 23098125
J Neurol Sci. 2015 Aug 15;355(1-2):155-61
pubmed: 26092373
Neurology. 2014 Sep 2;83(10):920-8
pubmed: 25098535
Trends Endocrinol Metab. 2002 Apr;13(3):100-5
pubmed: 11893522
Br J Psychiatry. 2013 Feb;202:100-7
pubmed: 23377209
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Neurol Sci. 2014 Dec;35(12):1947-53
pubmed: 25008423
BMC Psychiatry. 2014 May 08;14:134
pubmed: 24884774
Biochem Med (Zagreb). 2015 Oct 15;25(3):430-8
pubmed: 26526462
J Prev Alzheimers Dis. 2016;3(1):43-52
pubmed: 29214280
Osteoporos Int. 2016 Mar;27(3):1199-1208
pubmed: 26468040
J Gerontol A Biol Sci Med Sci. 2014 Sep;69(9):1132-8
pubmed: 24568931
J Affect Disord. 2007 Aug;101(1-3):245-9
pubmed: 17184843
Mol Nutr Food Res. 2013 Feb;57(2):267-76
pubmed: 23281306
Dement Geriatr Cogn Disord. 2012;33(5):297-305
pubmed: 22759681
J Alzheimers Dis. 2013;37(1):147-71
pubmed: 23948884
Am J Clin Nutr. 2007 Oct;86(4):959-64
pubmed: 17921371
Am J Epidemiol. 2010 Apr 15;171(8):903-8
pubmed: 20219763
Dement Geriatr Cogn Disord. 2011;32(4):235-40
pubmed: 22156335
Ther Adv Musculoskelet Dis. 2017 Apr;9(4):97-104
pubmed: 28382113
Bone. 2004 Aug;35(2):412-7
pubmed: 15268891
Exp Gerontol. 2017 Apr;90:90-97
pubmed: 28167237
J Intern Med. 2004 Sep;256(3):240-6
pubmed: 15324367
J Nutr. 2010 Mar;140(3):595-9
pubmed: 20089790
J Alzheimers Dis. 2016 Nov 19;55(2):717-725
pubmed: 27716664
J Am Med Dir Assoc. 2015 Jul 1;16(7):621-7
pubmed: 25838206
Dement Geriatr Cogn Disord. 2014;37(5-6):286-93
pubmed: 24356580
J Alzheimers Dis. 2011;25(2):295-307
pubmed: 21422528
Am J Clin Nutr. 2002 Apr;75(4):611-5
pubmed: 11916748
Nutrients. 2013 Mar 22;5(3):971-80
pubmed: 23525081